XK
CLVS

Xact Kapitalforvaltning’s Clovis Oncology, Inc. CLVS Stock Holding History

Xact Kapitalforvaltning’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-9,030
Closed -$224K – 1482
2019
Q1 		$224K Buy
+9,030
New +$226K 0.01% 1356
2018
Q4 		– Sell
-7,630
Closed -$224K – 1532
2018
Q3 		$224K Hold
7,630
– – ﹤0.01% 1499
2018
Q2 		$347K Buy
7,630
+500
+7% +$24.3K 0.01% 1227
2018
Q1 		$376K Buy
7,130
+2,300
+48% +$134K 0.01% 1029
2017
Q4 		$328K Buy
+4,830
New +$338K 0.01% 887

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Xact Kapitalforvaltning's CLVS Position: Q2 2019 in Review

Xact Kapitalforvaltning sold out of Clovis Oncology, Inc. (CLVS) in Q2 2019, closing a stake of 9,030 shares — an estimated $224K sold.

Xact Kapitalforvaltning first reported a position in CLVS in Q4 2017 and held it in 5 quarters. The position peaked at $376K in Q1 2018. 167 funds tracked by Wall St. Rank hold CLVS as of Q2 2019.

  • Xact Kapitalforvaltning reported no remaining Clovis Oncology, Inc. position as of Q2 2019 after selling out during the quarter.
  • Xact Kapitalforvaltning sold 9,030 Clovis Oncology, Inc. shares in Q2 2019, an estimated $224K.
  • Xact Kapitalforvaltning first reported a position in Clovis Oncology, Inc. in Q4 2017 and held it in 5 quarters.
  • Xact Kapitalforvaltning's Clovis Oncology, Inc. position peaked at $376K in Q1 2018.
  • 167 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2019.

Based on Xact Kapitalforvaltning's 13F filing for Q2 2019, filed 12 Jul 2019.